Lazarus syndrome in nonsmall cell lung cancer patients with poor performance status and major leukocytosis following nivolumab treatment

Eur Respir J. 2017 Jul 27;50(1):1700310. doi: 10.1183/13993003.00310-2017. Print 2017 Jul.

Johan Pluvy^{1

2}, Solenn Brosseau^{1

2}, Charles Naltet^{1

2}, Marie-Agnès Opsomer³, Aurélie Cazes⁴, Claire Danel⁴, Antoine Khalil⁵, Gérard Zalcman^{1

2}, Valerie Gounant^{6

2}

¹ Thoracic Oncology Dept, Paris-Diderot University, Bichat Hospital (APHP), Paris, France.
² Early Phase Trials Unit CIC14-25, CLIP2 Paris-Nord, Bichat Hospital (APHP), Paris, France.
³ Pharmacy Dept, Bichat Hospital (APHP), Paris, France.
⁴ Pathology Dept, Paris-Diderot University, Bichat Hospital (APHP), Paris, France.
⁵ Radiology Dept, Paris-Diderot University, Bichat Hospital (APHP), Paris, France.
⁶ Thoracic Oncology Dept, Paris-Diderot University, Bichat Hospital (APHP), Paris, France valerie.gounant@aphp.fr.

No abstract available

Publication types